Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long‐acting β 2 ‐agonists in obstructive lung diseases: a population‐based, observational study-Reference-Cited by-同舟云学术

Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long‐acting β 2 ‐agonists in obstructive lung diseases: a population‐based, observational study

Published:2014-06-18 Issue:7 Volume:68 Page:812-819
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Björnsdóttir U. S.¹,Sigurðardóttir S. T.¹²,Jonsson J. S.³⁴,Jonsson M.⁵,Telg G.⁶,Thuresson M.⁷,Naya I.⁸,Gizurarson S.⁹

Affiliation:

1. Faculty of Medicine University of Iceland Reykjavik Iceland

2. Department of Immunology Landspitali – The National University Hospital of Iceland Reykjavik Iceland

3. Heilsugæslan Gardabaer Gardabaer Iceland

4. Faculty of Family Medicine University of Iceland Reykjavik Iceland

5. Department of Respiratory Medicine, Allergy and Sleep Landspitali – The National University Hospital of Iceland Reykjavik Iceland

6. AstraZeneca Nordic Södertälje Sweden

7. Statisticon AB Uppsala Sweden

8. Formerly of AstraZeneca R&D Macclesfield UK

9. Faculty of Pharmaceutical Sciences University of Iceland Reykjavik Iceland

Funder

Astra Zeneca

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.12473

Reference27 articles.

1. Global Strategy for Asthma Management and Prevention 2012.http://www.ginasthma.org/(accessed 7 February 2014).

2. Global Strategy for Diagnosis Management and Prevention of COPD 2011.http://www.goldcopd.org/(accessed 7 February 2014).

3. Long-Acting β2-Agonist Step-off in Patients With Controlled Asthma

4. Short-acting β2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting β2-agonist or salmeterol/fluticasone propionate combination

5. What happens to patients who have their asthma device switched without their consent?

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods to assess COPD medications adherence in healthcare databases: a systematic review;European Respiratory Review;2023-09-27

2. The impact of unsupervised and unconsented switch of inhalers in patients with controlled asthma – A targeted literature review;Annals of Thoracic Medicine;2023

3. Defined daily dose definition in medication adherence assessment in asthma;European Clinical Respiratory Journal;2023-01

4. Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries;BMJ Open Respiratory Research;2021-12

5. Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England;Journal of Health Economics and Outcomes Research;2021-09-23